Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1DV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,416
Award facts
- Contract value 100% obligated
- $68,415.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $68,415.66 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of January 14, 2026, was awarded without set-aside designation through full and open competition. The contract is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which authorizes the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical vendor for federal medical procurement and consistently demonstrates capability to fulfill competitive pharmaceutical supply requirements for the Defense Logistics Agency and other federal healthcare systems. The Trelegy Ellipta product supplied under this order is a combination inhaler used in respiratory disease management, reflecting the company's role in delivering specialized medications across multiple therapeutic domains to military treatment facilities and other federal medical institutions. AmerisourceBergen's extensive contract portfolio with DLA and the Department of Veterans Affairs underscores its position as a major pharmaceutical distributor within the federal supply chain.
Quick answers
Who was awarded contract SPE2DR26FA1DV?
SPE2DR26FA1DV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FA1DV worth?
The government has obligated $68,416 on SPE2DR26FA1DV.
Is contract SPE2DR26FA1DV an order under another contract?
Yes. SPE2DR26FA1DV is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1DV competed?
The extent of competition for SPE2DR26FA1DV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award